Globeflex Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $691K | Hold |
10,597
| – | – | 0.06% | 229 |
|
|
2025
Q1 | $709K | Hold |
10,597
| – | – | 0.07% | 217 |
|
|
2024
Q4 | $586K | Hold |
10,597
| – | – | 0.05% | 253 |
|
|
2024
Q3 | $632K | Hold |
10,597
| – | – | 0.06% | 238 |
|
|
2024
Q2 | $675K | Sell |
10,597
-1,052
| -9% | -$67K | 0.07% | 220 |
|
|
2024
Q1 | $805K | Sell |
11,649
-1,257
| -10% | -$86.9K | 0.08% | 212 |
|
|
2023
Q4 | $712K | Hold |
12,906
| – | – | 0.07% | 232 |
|
|
2023
Q3 | $749K | Buy |
12,906
+6,306
| +96% | +$366K | 0.09% | 207 |
|
|
2023
Q2 | $355K | Buy |
+6,600
| New | +$355K | 0.04% | 283 |
|
|
2022
Q2 | – | Sell |
-21,919
| Closed | -$616K | – | 482 |
|
|
2022
Q1 | $616K | Hold |
21,919
| – | – | 0.12% | 206 |
|
|
2021
Q4 | $1.01M | Hold |
21,919
| – | – | 0.21% | 157 |
|
|
2021
Q3 | $719K | Hold |
21,919
| – | – | 0.16% | 200 |
|
|
2021
Q2 | $768K | Hold |
21,919
| – | – | 0.14% | 231 |
|
|
2021
Q1 | $792K | Hold |
21,919
| – | – | 0.14% | 229 |
|
|
2020
Q4 | $637K | Sell |
21,919
-19,293
| -47% | -$561K | 0.14% | 246 |
|
|
2020
Q3 | $1.16M | Buy |
41,212
+1,755
| +4% | +$49.5K | 0.31% | 93 |
|
|
2020
Q2 | $1.28M | Buy |
39,457
+1,302
| +3% | +$42.1K | 0.32% | 82 |
|
|
2020
Q1 | $1.55M | Sell |
38,155
-811
| -2% | -$33K | 0.48% | 39 |
|
|
2019
Q4 | $2.4M | Buy |
38,966
+9,126
| +31% | +$563K | 0.45% | 38 |
|
|
2019
Q3 | $2.18M | Buy |
29,840
+2,138
| +8% | +$156K | 0.48% | 39 |
|
|
2019
Q2 | $2.28M | Hold |
27,702
| – | – | 0.47% | 39 |
|
|
2019
Q1 | $1.95M | Buy |
27,702
+17,802
| +180% | +$1.26M | 0.41% | 51 |
|
|
2018
Q4 | $446K | Hold |
9,900
| – | – | 0.11% | 293 |
|
|
2018
Q3 | $560K | Sell |
9,900
-2,400
| -20% | -$136K | 0.11% | 280 |
|
|
2018
Q2 | $822K | Buy |
12,300
+1,200
| +11% | +$80.2K | 0.17% | 209 |
|
|
2018
Q1 | $646K | Sell |
11,100
-17,515
| -61% | -$1.02M | 0.14% | 247 |
|
|
2017
Q4 | $1.84M | Buy |
28,615
+1,700
| +6% | +$110K | 0.51% | 39 |
|
|
2017
Q3 | $1.41M | Buy |
+26,915
| New | +$1.41M | 0.4% | 70 |
|